SIB 1893

Drug Profile

SIB 1893

Alternative Names: 2-Methyl-6-(phenylethenyl) pyridine

Latest Information Update: 06 Apr 2010

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Merck & Co
  • Class Antiepileptic drugs; Neuroprotectants
  • Mechanism of Action Metabotropic glutamate receptor 5 antagonists; NMDA receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Neurological disorders

Most Recent Events

  • 06 Apr 2010 No development reported - Preclinical for Neurological disorders (Prevention) in USA (unspecified route)
  • 20 Aug 2002 This compound is still in active development
  • 11 Dec 2000 Preclinical development for Neurological disorders (Prevention) in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top